Market Tracker

05/26 10:32am ET

Inovio Pharmaceuticals Inc (NASDAQ:INO)

10.96
BATS BZX Real-Time Price
As of 10:32am ET
 -0.20 / -1.79%
Today’s Change
4.50
Today|||52-Week Range
11.69
+63.10%
Year-to-Date
5 Things You Need to Know About Zika Virus
9:26am / MotleyFool.com - Paid Partner Content
5 Things Inovio Pharmaceuticals Inc. Management Wants You to Know
May 13 / MotleyFool.com - Paid Partner Content
Inovio Pharmaceuticals' Zika Vaccine Takes a Big Step Forward
May 17 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close11.16
Today’s open11.20
Day’s range10.87 - 11.20
Volume16,550
Average volume (3 months)1,998,890
Market cap$815.8M
Dividend yield--
Data as of 10:32am ET, 05/26/2016

Growth & Valuation

Earnings growth (last year)+31.25%
Earnings growth (this year)--
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+288.00%
P/E ratioNM
Price/Sales11.32
Price/Book4.59

Competitors

 Today’s
change
Today’s
% change
MNTAMomenta Pharmaceutic...-0.02-0.18%
CHRSCoherus BioSciences ...+0.01+0.05%
ADAPAdaptimmune Therapeu...-0.16-1.56%
RLYPRelypsa Inc+0.22+1.36%
Data as of 10:32am ET, 05/26/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$40.6M
Annual profit (last year)-$29.2M
Net profit margin-71.94%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
J. Joseph Kim
Chief Operating Officer
Niranjan Y. Sardesai
Corporate headquarters
Plymouth Meeting, Pennsylvania

Forecasts